Tcw Group Trimmed Its Illumina (ILMN) Stake by $1.23 Million as Stock Rose; Gilead Sciences (GILD) Shareholder Brookmont Capital Management Has Lifted Its Holding by $1.54 Million as Valuation Rose

April 17, 2018 - By Michael Collier

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Brookmont Capital Management increased its stake in Gilead Sciences Inc (GILD) by 49.97% based on its latest 2017Q4 regulatory filing with the SEC. Brookmont Capital Management bought 21,628 shares as the company’s stock rose 1.93% while stock markets declined. The institutional investor held 64,914 shares of the health care company at the end of 2017Q4, valued at $4.65 million, up from 43,286 at the end of the previous reported quarter. Brookmont Capital Management who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $98.57 billion market cap company. The stock increased 1.22% or $0.91 during the last trading session, reaching $75.6. About 3.30M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 9.79% since April 17, 2017 and is uptrending. It has underperformed by 1.76% the S&P500.

Tcw Group Inc decreased its stake in Illumina Inc (ILMN) by 1.9% based on its latest 2017Q4 regulatory filing with the SEC. Tcw Group Inc sold 5,664 shares as the company’s stock rose 10.04% while stock markets declined. The institutional investor held 293,199 shares of the capital goods company at the end of 2017Q4, valued at $64.06M, down from 298,863 at the end of the previous reported quarter. Tcw Group Inc who had been investing in Illumina Inc for a number of months, seems to be less bullish one the $36.53B market cap company. The stock increased 1.52% or $3.73 during the last trading session, reaching $248.92. About 649,574 shares traded. Illumina, Inc. (NASDAQ:ILMN) has risen 37.77% since April 17, 2017 and is uptrending. It has outperformed by 26.22% the S&P500.

Investors sentiment decreased to 0.8 in Q4 2017. Its down 0.23, from 1.03 in 2017Q3. It turned negative, as 95 investors sold GILD shares while 545 reduced holdings. 104 funds opened positions while 411 raised stakes. 972.68 million shares or 1.57% more from 957.62 million shares in 2017Q3 were reported. Atwood & Palmer has 2.28% invested in Gilead Sciences, Inc. (NASDAQ:GILD). B And T Cap Dba Alpha Cap has invested 1.12% in Gilead Sciences, Inc. (NASDAQ:GILD). Channing Capital Mngmt Lc holds 0.27% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) for 110,418 shares. Wealthtrust Axiom Lc holds 19,317 shares or 0.51% of its portfolio. First Fincl Corporation In accumulated 0.01% or 185 shares. Valley Natl Advisers Incorporated has invested 0.04% in Gilead Sciences, Inc. (NASDAQ:GILD). Fulton Bank Na accumulated 49,219 shares or 0.25% of the stock. Moreover, Bowling Management Ltd Liability Co has 0.21% invested in Gilead Sciences, Inc. (NASDAQ:GILD). Waldron Lp invested in 4,720 shares or 0.08% of the stock. Pinnacle Associates stated it has 291,973 shares. American Beacon Advsrs Incorporated holds 2,671 shares or 2.05% of its portfolio. Neumann Cap Lc reported 50,770 shares or 2.23% of all its holdings. Wafra Invest Advisory Grp Inc Ny reported 0.38% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). British Columbia Investment Mngmt Corp, British Columbia – Canada-based fund reported 742,048 shares. Florida-based Aviance Cap Prtnrs Limited Company has invested 0.42% in Gilead Sciences, Inc. (NASDAQ:GILD).

Among 30 analysts covering Gilead Sciences (NASDAQ:GILD), 21 have Buy rating, 0 Sell and 9 Hold. Therefore 70% are positive. Gilead Sciences had 126 analyst reports since July 29, 2015 according to SRatingsIntel. The firm has “Equal-Weight” rating by Morgan Stanley given on Friday, October 2. Mizuho maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Sunday, October 29 with “Buy” rating. Berenberg initiated Gilead Sciences, Inc. (NASDAQ:GILD) rating on Monday, September 12. Berenberg has “Buy” rating and $112 target. The rating was maintained by BMO Capital Markets on Friday, July 21 with “Hold”. Mizuho maintained it with “Buy” rating and $83.0 target in Wednesday, November 8 report. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Outperform” rating by Credit Suisse on Wednesday, January 20. As per Tuesday, September 27, the company rating was downgraded by Leerink Swann. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Friday, September 15 by Robert W. Baird. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) earned “Hold” rating by Jefferies on Wednesday, August 31. BMO Capital Markets maintained the shares of GILD in report on Thursday, July 27 with “Hold” rating.

Brookmont Capital Management, which manages about $415.17 million and $231.96M US Long portfolio, decreased its stake in Home Depot Inc (NYSE:HD) by 147,328 shares to 47,283 shares, valued at $8.96M in 2017Q4, according to the filing.

Since January 2, 2018, it had 0 buys, and 17 selling transactions for $39.51 million activity. Alton Gregg H sold $1.18M worth of stock. Shares for $8.02 million were sold by Meyers James R. On Wednesday, February 21 Washington Robin L sold $401,566 worth of Gilead Sciences, Inc. (NASDAQ:GILD) or 5,000 shares. 50,000 shares valued at $3.68M were sold by MARTIN JOHN C on Tuesday, January 2. On Friday, February 9 the insider WILSON GAYLE E sold $4.68 million.

Among 28 analysts covering Illumina Inc (NASDAQ:ILMN), 19 have Buy rating, 1 Sell and 8 Hold. Therefore 68% are positive. Illumina Inc had 96 analyst reports since July 22, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cowen & Co on Wednesday, October 25. Morgan Stanley maintained the shares of ILMN in report on Wednesday, December 7 with “Underweight” rating. The firm has “Neutral” rating by Citigroup given on Tuesday, October 11. Argus Research initiated the shares of ILMN in report on Wednesday, March 30 with “Buy” rating. First Analysis downgraded Illumina, Inc. (NASDAQ:ILMN) on Wednesday, November 2 to “Underweight” rating. Citigroup maintained it with “Buy” rating and $275 target in Tuesday, February 6 report. The company was maintained on Wednesday, October 21 by Piper Jaffray. First Analysis upgraded Illumina, Inc. (NASDAQ:ILMN) rating on Wednesday, January 31. First Analysis has “Buy” rating and $277.0 target. The stock of Illumina, Inc. (NASDAQ:ILMN) has “Outperform” rating given on Monday, March 20 by Leerink Swann. Canaccord Genuity maintained Illumina, Inc. (NASDAQ:ILMN) rating on Thursday, October 12. Canaccord Genuity has “Buy” rating and $230.0 target.

Tcw Group Inc, which manages about $12.42B US Long portfolio, upped its stake in Broadcom Ltd by 21,849 shares to 137,278 shares, valued at $35.27 million in 2017Q4, according to the filing. It also increased its holding in Schlumberger Ltd (NYSE:SLB) by 22,769 shares in the quarter, for a total of 427,067 shares, and has risen its stake in Trinity Inds Inc (NYSE:TRN).

Since October 24, 2017, it had 0 insider buys, and 21 sales for $18.11 million activity. $356,535 worth of stock was sold by Dadswell Charles on Monday, February 5. $692,448 worth of Illumina, Inc. (NASDAQ:ILMN) was sold by BOWMAN A BLAINE. Van Oene Mark sold $333,872 worth of Illumina, Inc. (NASDAQ:ILMN) on Thursday, April 12. 2,000 shares were sold by EASTHAM KARIN, worth $458,735 on Monday, March 5. $305,225 worth of Illumina, Inc. (NASDAQ:ILMN) shares were sold by EPSTEIN ROBERT S. $413,759 worth of stock was sold by Stapley Marc on Thursday, October 26.

Analysts await Illumina, Inc. (NASDAQ:ILMN) to report earnings on April, 24 after the close. They expect $1.02 earnings per share, up 59.38% or $0.38 from last year’s $0.64 per share. ILMN’s profit will be $149.68 million for 61.01 P/E if the $1.02 EPS becomes a reality. After $1.44 actual earnings per share reported by Illumina, Inc. for the previous quarter, Wall Street now forecasts -29.17% negative EPS growth.

Investors sentiment increased to 1.39 in 2017 Q4. Its up 0.29, from 1.1 in 2017Q3. It is positive, as 29 investors sold ILMN shares while 161 reduced holdings. 86 funds opened positions while 179 raised stakes. 130.72 million shares or 0.63% less from 131.54 million shares in 2017Q3 were reported. Point72 Asset Mngmt Lp reported 0.08% stake. Kentucky Retirement Insur Trust Fund reported 3,877 shares. Federated Investors Pa, Pennsylvania-based fund reported 15,439 shares. Perigon Wealth Management Ltd Llc invested 0.01% in Illumina, Inc. (NASDAQ:ILMN). Capital Guardian Tru Communications has 3,255 shares for 0.01% of their portfolio. Voloridge Management Ltd Limited Liability Company owns 12,606 shares or 0.06% of their US portfolio. Washington Management has invested 0.31% in Illumina, Inc. (NASDAQ:ILMN). Ahl Prtnrs Llp invested in 5,760 shares or 0.02% of the stock. Oppenheimer Asset invested in 0.1% or 18,892 shares. First Personal Fin Services, North Carolina-based fund reported 181 shares. Putnam Invests Limited Co holds 2,176 shares. Ngam Advsr Limited Partnership stated it has 10,383 shares. Eaton Vance stated it has 29,436 shares. Sivik Global Limited Liability Company holds 1.22% or 15,000 shares. 8,374 were reported by Millennium Limited Liability.

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Michael Collier

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts